Monitoring and improving the quality of breast imaging is essential to regulatory compliance, reducing the number of image retakes, improving clinic performance and most importantly, reducing the rate of breast cancer mortality.
Over the last six months, 40 per cent of breast screening centres in the US were found to be deficient in their quality assurance program under the FDA’s EQUIP Mammography Quality Initiative. This is where VolparaEnterprise will have the biggest impact – supporting clinics to better manage quality. Our cloud based software provides feedback to the technologists on a range of metrics including breast density, positioning, compression and radiation dosage.
